Befovacimab

Tax included
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research.
MedChemExpress 
HY-P99465

Data sheet

Size
Multiple sizes
Reactivity
Thrombin
CAS
2156634-62-5